36B6:F:F-iShares MSCI USA SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 9.512

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.28 (-1.06%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.70%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.28 (-0.51%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.23 (+0.24%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.42 (+0.28%)

USD 37.92B

ETFs Containing 36B6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.06% 62% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.06% 59% D- 57% F
Trailing 12 Months  
Capital Gain 15.35% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.35% 64% D 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.20% 53% F 56% F
Dividend Return 4.20% 51% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.27% 73% C 91% A-
Risk Adjusted Return 50.76% 61% D- 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike